Clinical Trial Update: Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of Abraxane in patients with visceral metastases-dominant metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED